Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

33.97
Delayed Data
As of Jan 13
 +0.03 / +0.09%
Today’s Change
33.56
Today|||52-Week Range
65.20
-6.29%
Year-to-Date
Rhenman & Partners Asset Management AB Buys Gilead Sciences Inc, Medtronic PLC, Pfize...
Jan 13 / GuruFocus News - Paid Partner Content
Teva May Have Found a Cure for Last Year
Jan 11 / TheStreet.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Addison Capital Co Buys Stericycle Inc, PayPal Holdings Inc, KeyCorp, Sells CST Brand...
Jan 10 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
Jan 10 / TheStreet.com - Paid Partner Content
Patent Victory Secures Lilly Hold on Cancer Drug Until 2022
Jan 12 / TheStreet.com - Paid Partner Content
Merrimack (MACK) Sells Onivyde Rights to Ipsen for $1B
Jan 09 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for January 11th
Jan 11 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks Selling for a Discount This Winter
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close33.94
Today’s open34.25
Day’s range33.86 - 34.47
Volume12,592,066
Average volume (3 months)9,090,112
Market cap$34.5B
Dividend yield4.00%
Data as of 01/13/2017

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-5.34%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-3.22%
P/E ratio19.6
Price/Sales2.89
Price/Book1.16

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.84+2.64%
OASMOasmia Pharmaceutica...-0.11-3.82%
Data as of 01/13/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.36
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts


Search for Jobs